Markets
The man behind an innovative exercise and rehabilitation system to screen patients at risk of serious falls, believes it will "revolutionise" the way the primary care sector deals with what has become a massive global problem linked to ageing. Tim Henson has spent the last decade and hundreds of thousands of pounds developing the Formula [...]
A new drug combo has been shown to boost metastasis-free survival by 58% in prostate cancer patients at high risk of biochemical recurrence. Astellas Pharma and Pfizer say the drug Xtandi combined with an androgen deprivation therapy has the potential to be the new standard of care in patients with high risk biochemical recurrence (BCR) [...]
The first ever drug to treat an acute form of dry age-related macular degeneration (AMD) has been approved in the United States. Pegcetacoplan, also known as Syfovre, has been cleared for use in patients by the Food and Drug Administration (FDA). Until now there has been no treatment for the severe form of dry AMD [...]
The market for brain supplements is expected to grow by US $4,020.62m in the next four years - driven largely by an ageing global population. Thriving urban communities and a rise in the number of retail sales outlets, are also expected to help push up the compound annual growth rate (CAGR) by 8.18% between now [...]
A new twist on a drug used to treat alcohol use disorder could double up as a treatment for stroke. Carb - short for Carbamathione - is a new formulation designed to treat ischemic stroke, protect brain tissue against injury and minimise the size of localised brain damage. About 87% of all strokes are caused [...]
Digital health company, NeuroRPM, has received FDA clearance for its artificial intelligence (AI)-powered remote monitoring app for Parkinson’s disease. The product uses AI and Apple Watch to continuously and passively monitor bradykinesia, tremor, and dyskinesia, the cardinal symptoms of Parkinson's disease. The product includes advanced, comprehensive monitoring capabilities for Parkinson’s disease available on a wearable [...]
Digital health company, Biostarks, has announced the launch of two new at-home test kits to measure a range of indicators for optimum health and longevity. After entering the nutrition and sport markets with two respective at-home test kits leveraging its mass-spectrometry platform, the company is expanding its offering in the fast-growing longevity market with two [...]
Health Gauge has successfully completed a blood pressure validation study on its AI-powered wearable health monitoring device. AI/ML Innovations Inc, has reported that its subsidiary, Health Gauge Inc, has successfully completed a blood pressure validation study on its wearable health monitoring solution, the Phoenix. Health Gauge’s personal health monitoring and management system combines wearable health [...]
A novel drug has been shown in preclinical studies to be effective in improving grip strength and motor coordination in a model of Parkinson’s disease. Jupiter Neurosciences, a clinical-stage pharmaceutical company focused on the treatment of central nervous system (CNS) disorders and rare diseases, has announced preclinical data from its proprietary drug product, JOTROL™, for [...]
Melax Tech and Brigham and Women's Hospital in Boston have been awarded a grant of USD$2.5 million by the National Institute of Health (NIH) for research into the early detection of dementia. The project, led by specialists in biomedical natural language processing (NLP), aims to build and validate a clinical decision support system (CDS) for [...]
